Crystal Structure of an LSD-Bound Human Serotonin Receptor

Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., ... & Shoichet, B. K. | Cell | 26 January 2017

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects

Strajhar, P., Schmid, Y., Liakoni, E., Dolder, P. C., Rentsch, K. M., Kratschmar, D. V., ... & Liechti, M. E. | Journal of neuroendocrinology | 1 January 2017

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. | International Journal of Molecular Sciences | 23 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016

Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use

Morgan, C., McAndrew, A., Stevens, T., Nutt, D., & Lawn, W. | Current Opinion in Behavioral Sciences | 15 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016

Rehabilitating LSD history in postwar America: Dilworth Wayne Woolley and the serotonin hypothesis of mental illness

Hewitt, K. | History of Science | 2 November 2016

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm

Hendricks, P. S., & Grob, C. S. | Rational Suicide in the Elderly | 29 October 2016

Creativity and Psychoactive Substance Use: A Systematic Review

Iszáj, F., Griffiths, M. D., & Demetrovics, Z. | International Journal of Mental Health and Addiction | 20 October 2016

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Liechti, M. E., Dolder, P. C., & Schmid, Y. | Psychopharmacology | 7 October 2016

Psychedelics in the treatment of unipolar mood disorders: A systematic review

Rucker, J. J., Jelen, L. A., Flynn, S., Frowde, K. D., & Young, A. H. | Journal of Psychopharmacology | 1 October 2016

Lysergic Acid Diethylamide and mystical experiences

Lyvers, M. | The neuropathology of drug addictions and substance misuse | 1 October 2016

The Entheogen Reformation

Roberts, T. B. | Association for Transpersonal Psychology | 1 October 2016

Psychedelic Psychotherapy Insights From 25 Years of Research

Richards, W. A. | Journal of Humanistic Psychology | 29 September 2016

The Resurrection Of Psychedelic Psychiatry And Its Role In Addiction Treatment

Skocylas, R. | UBC Medical Journal | 1 September 2016

DPS en HPPD: signalering, diagnostiek en behandeling van persistente waarnemingsstoornissen na partydrugs

Alderliefste, G. J. | Verslaving | 30 August 2016

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. | Pharmacological Research | 17 August 2016

The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

Sweat, N. W., Bates, L. W., & Hendricks, P. S. | Journal of Psychoactive Drugs | 11 August 2016

Semantic activation in LSD: evidence from picture naming

Family, N., Vinson, D., Vigliocco, G., Kaelen, M., Bolstridge, M., Nutt, D. J., & Carhart-Harris, R. L. | Language, Cognition and Neuroscience | 11 August 2016

Acid Brothers: Henry Beecher, Timothy Leary, and the psychedelic of the century

Moreno, J. D. | Perspectives in Biology and Medicine | 1 August 2016

Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics

Tófoli, L. F., & de Araujo, D. B. | International Review of Neurobiology | 25 July 2016

From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide

Mucke, H. A. | ASSAY and Drug Development Technologies | 8 July 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Colestock, T., ... & Halberstadt, A. L. | Drug testing and analysis | 6 June 2016